Category: Medicine Page 4 of 9

Of course there will be medicine. I am The Grumpy Doc.

When someone tells you they’re having trouble remembering where they put their keys, that’s probably just normal aging. But when they forget what keys are for altogether, that’s when doctors start thinking about dementia. It’s a distinction that matters deeply to millions of families navigating one of medicine’s most challenging conditions.

While reviewing some of my previous articles, I realized that while I have discussed conditions that mimic dementia, I haven’t discussed dementia itself. This discussion has quite a bit of technical jargon, but it’s unavoidable.

Dementia isn’t a specific disease—it’s an umbrella term describing a decline in mental ability that interferes with daily life. Think of it like how “cancer” describes many different diseases. About 50 percent of people age 85 and older have some form of dementia, making it one of the most pressing health challenges of our aging population.

The Major Players: Types of Dementia

Alzheimer’s Disease stands as the heavyweight champion of dementia causes, accounting for an estimated 50 to 70 percent of all cases. What’s happening in the brain is both complicated and tragic. Beta-amyloid and phosphorylated tau proteins accumulate and spread through distributed neural networks in the brain, causing progressive metabolic abnormalities, neuronal injury, and cellular death all of which disrupt functional connectivity. The hallmark symptoms include problems with short-term memory: paying bills, preparing meals, remembering appointments, or getting lost in familiar areas. Your grandmother might remember vivid details from her childhood but can’t recall what she ate for breakfast or even recognize you.

Vascular Dementia comes in second place, accounting for about 5 to 15 percent of cases. Typical symptoms include slowed thinking, trouble with organization, difficulty planning or following instructions, and in the later phases, gait problems and urinary difficulties. It results from strokes or other problems with blood flow to the brain. On occasion it may be the result of a series of subclinical strokes with the victim being unaware of the individual events. Symptoms gradually become worse as blood vessels get damaged. Imagine the brain like a city—when the roads get blocked, supplies can’t get through, and neighborhoods start to fail.

Lewy Body Dementia Involves the deposit of abnormal alpha-synuclein proteins called Lewy bodies. It presents a particularly unsettling picture. Many people with this type of dementia experience daytime sleepiness, confusion, fluctuating cognition, staring spells, sleep disturbances, visual hallucinations, or movement problems. The visual hallucinations are generally vivid images of people or animals and often occur when someone is about to fall asleep or wake up.

Frontotemporal Dementia often hits younger people. It is caused by abnormalities in the proteins FUS and TDP-43. Most cases are diagnosed in people aged 45 to 65. Rather than starting with memory loss, early symptoms may include personality changes like reduced sensitivity to others’ feelings, lack of social awareness, making inappropriate jokes, language problems, obsessive behavior, or sudden outbursts of anger. It’s heartbreaking when someone’s personality fundamentally changes before your eyes.

LATE is a newly recognized form of dementia (Limbic-predominant Age-related TDP-43 Encephalopathy), which causes symptoms similar to Alzheimer’s but has different underlying causes involving abnormal clusters of TDP-43 protein. Research suggests that almost 40 percent of people whose age at death was 88 years or greater may have had LATE of varying degrees.

Less Common Forms: Parkinson’s disease dementia (movement disorder first, dementia later).Normal Pressure Hydrocephalus (NPH)—one of the few reversible types. Chronic traumatic encephalopathy (CTE)—linked to repeated head injuries.HIV-associated dementia—less common with modern treatment. Severe vitamin deficiencies (e.g., B1 or B12)—reversible if caught early.

Figuring Out What’s Wrong: The Diagnostic Process

Making a dementia diagnosis isn’t like getting a strep test or an Xray—there’s no single definitive test. Physicians use diagnostic tools combined with medical history and other information, including neurological exams, cognitive and functional assessments, brain imaging like MRI or CT, and cerebrospinal fluid or blood tests.

The process starts with your doctor asking detailed questions about your symptoms and medical history. Typical questions include asking about whether dementia runs in the family, how and when symptoms began, changes in behavior and personality, and if the person is taking certain medications that might cause or worsen symptoms. There are various cognitive tests—like the infamous clock face drawing—that physicians can use to assess the likelihood of dementia.

Brain imaging can play a crucial role for some patients. Structural imaging with MRI or CT is primarily used to rule out other conditions that may cause symptoms similar to dementia but that require different treatment. They can reveal tumors, evidence of strokes, damage from head trauma, or fluid buildup in the brain. Common MRI findings include brain atrophy, particularly shrinkage of the hippocampus which supports learning and memory and the cortex which supports perception, thought and voluntary action. Other findings may include white matter changes that affect communication between brain regions. Lesions from small strokes may be identified.

More sophisticated imaging like PET scans can detect specific proteins associated with Alzheimer’s. Recent advances in molecular imaging allow for visualization of amyloid and tau deposits in a living human brain, bringing us closer to an in vivo (while alive) definitive diagnosis. This is significant because historically Alzheimer’s could only be definitively diagnosed at autopsy.

Treatment Options: Managing the Unmanageable

Here’s where I need to be honest: there’s no cure for dementia. But that doesn’t mean we’re helpless. Several medications can help manage symptoms and potentially slow progression.

For Alzheimer’s specifically, the FDA has approved two categories of drugs. These include drugs that change disease progression in people living with early Alzheimer’s disease, and drugs that may temporarily mitigate some symptoms. The newer disease-modifying drugs include donanemab and lecanemab. They are anti-amyloid antibody intravenous infusion therapies that have demonstrated that removing beta-amyloid from the brain reduces cognitive and functional decline in people living with early Alzheimer’s.

More traditional treatments focus on symptom management. Medications such as galantamine, rivastigmine, and donepezil improve communication between nerve cells. Cholinesterase inhibitors work by preventing the breakdown of acetylcholine, a neurotransmitter, which may stabilize dementia symptoms.

Beyond medications, lifestyle modifications matter. Lifestyle changes including eating a balanced diet full of fruits and vegetables may help slow progression. Maintaining a routine to avoid confusion, including regular exercise and sleep, all help keep people with dementia as functional as possible for as long as possible. Staying mentally active and socially connected can help slow the onset and progression of dementia.

What to Expect: The Prognosis

This is the hardest part to talk about. The life expectancy of dementia patients varies enormously. Most people older than 65 with Alzheimer’s die within four to eight years of being diagnosed, but some people live for decades, especially if they were diagnosed before turning 65.

Life expectancy depends on a huge range of factors including the type of dementia diagnosed, overall health, and the age of diagnosis. Vascular dementia typically has a shorter life expectancy than Alzheimer’s disease due to underlying cardiovascular problems.

Progression happens in stages. Early symptoms include finding it hard to carry out familiar daily tasks, struggling to follow conversations or find the right word, and getting confused with familiar places. Signs of late-stage dementia include speaking in single words or repeated phrases that don’t make sense, not being able to understand what people are saying, or following things that are happening around them.

Those living with advanced dementia are especially prone to infection, constipation, skin ulcers and blood clots, which can put their life in danger if treatment is delayed. Dehydration and malnutrition are serious risks for those without a strong support network as they often forget to eat or drink. They are also more likely to be injured in falls and other accidents.

Ultimately, as you lose more brain function, activities vital to life begin to be affected, including breathing, swallowing, digestion, heart rate and sleep. Most people don’t die directly from dementia but from complications like pneumonia or falls.

A Note on Hope

Reading about dementia can feel depressing, but there’s reason for cautious optimism. While individual prognosis varies significantly and can’t be predicted with precision, early detection of symptoms and an early diagnosis can help with planning ahead to manage the disease. Scientists continue researching new treatments, particularly regarding new biomarkers and disease modifying drugs. Life expectancy estimates are improving all the time as many people are diagnosed earlier and receive better treatment and care.

________________________________________________________________________

Sources

National Institute on Aging – What Is Dementia? Symptoms, Types, and Diagnosis https://www.nia.nih.gov/health/alzheimers-and-dementia/what-dementia-symptoms-types-and-diagnosis
NHS – Symptoms of Dementia https://www.nhs.uk/conditions/dementia/symptoms-and-diagnosis/symptoms/
Cleveland Clinic – Dementia: What It Is, Causes, Symptoms, Treatment & Types https://my.clevelandclinic.org/health/diseases/9170-dementia
CDC – About Dementia https://www.cdc.gov/alzheimers-dementia/about/index.html
Cleveland Clinic – Alzheimer’s Disease: Symptoms & Treatment https://my.clevelandclinic.org/health/diseases/9164-alzheimers-disease
Wikipedia – Dementia https://en.wikipedia.org/wiki/Dementia
Practical Neurology – Brain Imaging in Differential Diagnosis of Dementia https://practicalneurology.com/diseases-diagnoses/imaging-testing/brain-imaging-in-differential-diagnosis-of-dementia/31533/
Healthgrades – Vascular Dementia Life Expectancy: Statistics and Disease Progression https://resources.healthgrades.com/right-care/dementia/vascular-dementia-prognosis-and-life-expectancy
Healthgrades – Dementia Life Expectancy: Stages and Progression https://resources.healthgrades.com/right-care/dementia/dementia-prognosis-and-life-expectancy
Elder – Dementia and Life Expectancy: Planning for the Future https://www.elder.org/dementia-care/dementia-life-expectancy/
Medical News Today – Dementia Life Expectancy: Duration and Stages https://www.medicalnewstoday.com/articles/how-long-does-dementia-last
Alzheimer’s Association – Medications for Memory, Cognition & Dementia-Related Behaviors https://www.alz.org/alzheimers-dementia/treatments/medications-for-memory
Alzheimer’s Association – Medical Tests for Diagnosing Alzheimer’s & Dementia https://www.alz.org/alzheimers-dementia/diagnosis/medical_tests
DRI Health Group – Can MRI Diagnose Dementia? https://drihealthgroup.com/health-tips/can-mri-diagnose-dementia

America’s Healthcare Paradox: Why We Pay Double and Get Less

By John Turley

On January 5, 2026

In Commentary, Medicine

The healthcare debate in America often circles back to a fundamental question: should we move toward a single-payer system, or is our current mixed public-private model the better path forward? It’s a conversation that gets heated quickly, but when you strip away the politics and look at how different systems actually function around the world, some interesting patterns emerge.

What We Mean by Single-Payer

A single-payer healthcare system means that one entity—usually the government or a government-related organization—pays for all covered healthcare services. Doctors and hospitals can still be private (and usually are), but instead of dealing with dozens of different insurance companies, they bill one source. It’s a lot like Medicare, which is why proponents often call it “Medicare-for-all”.

The key thing to understand is that single-payer isn’t necessarily the same as socialized medicine. In Canada’s system, for instance, the government pays the bills, but doctors are largely in the private sector and hospitals are controlled by private boards or regional health authorities rather than being part of the national government. Compare that to the UK’s National Health Service, where many hospitals and clinics are government-owned and many doctors are government employees.

America’s Current Patchwork

The United States operates what might charitably be called a “creative” approach to healthcare—a complex mix of employer-sponsored private insurance, government programs like Medicare, Medicaid and the VA system, individual marketplace plans, and direct out-of-pocket payments. Government already pays roughly half of total US health spending, but benefits, cost-sharing, and networks vary widely between plans, with little overall coordination. In 2023, private health insurance spending accounted for 30 percent of total national health expenditures, Medicare covered 21 percent, and Medicaid covered 18 percent. Most of the remainder was either paid out of pocket by private citizens or was written off by providers as uncollectible.

Here’s where it gets expensive. U.S. health care spending grew 7.5 percent in 2023, reaching $4.9 trillion or $14,570 per person, accounting for 17.6 percent of the nation’s GDP, and national health spending for 2024 is expected to have exceeded $5.3 trillion or 18% of GDP, and health spending is expected to grow to 20.3 percent of GDP by 2033.

For a typical American family, the costs are real and rising. In 2024, the estimated cost of healthcare for a family of four in an employer-sponsored health plan was $32,066.

The European Landscape

Europe doesn’t have one healthcare model—it has several, and they’re all quite different from what we have in the States. Most of the 35 countries in the European Union have single-payer healthcare systems, but the details vary considerably.

Countries like the UK, Sweden, and Norway operate what are essentially single-payer systems where it is solely the government who pays for and provides healthcare services and directly owns most facilities and employs most clinical and related staff with funds from tax contributions. Then you have countries like Germany, and Belgium that use “sickness funds”—these are non-profit funds that don’t market, cherry pick patients, set premiums or rates paid to providers, determine benefits, earn profits or have investors. They’re quasi-public institutions, not private insurance companies like we know them in America. Some systems, such as the Netherlands or Switzerland, rely on mandatory individually purchased private insurance with tight regulation and subsidies, achieving universal coverage with a structured, competitive market.

The French System

France is particularly noted for a successful universal, government-run health insurance system usually described as a single-payer with supplements. All legal residents are automatically covered through the national health insurance program, which is funded by payroll taxes and general taxation.

Most physicians and hospitals are private or nonprofit, not government employees or facilities. Patients generally have free choice of doctors and specialists, though coordinating through a primary care physician improves access and reimbursement. The national insurer pays a large portion of medical costs (often 70–80%), while voluntary private supplemental insurance covers most remaining out-of-pocket expenses such as copays and deductibles.

France is known for spending significantly less per capita than the United States. Cost controls come from nationally negotiated fee schedules and drug pricing rather than limits on access.

What’s striking is that in 2019, US healthcare spending reached $11,072 per person—over double the average of $5,505 across wealthy European nations. Yet despite spending roughly twice as much per person, American health outcomes often lag behind.

The Outcomes Question

This is where the comparison gets uncomfortable for American exceptionalism. The U.S. has the lowest life expectancy at birth among comparable wealthy nations, the highest death rates for avoidable or treatable conditions, and the highest maternal and infant mortality.

In 2023, life expectancy in comparable countries was 82.5 years, which is 4.1 years longer than in the U.S. Japan manages this with healthcare spending at just $5,300 per capita, while Americans spend more than double that amount.

Now, it’s important to note that healthcare systems don’t operate in a vacuum. Life expectancy is influenced by many factors beyond medical care—diet, exercise, smoking, gun violence, drug overdoses, and social determinants of health all play roles. But when you’re spending twice as much and getting worse results, it suggests the system itself might be part of the problem.

Advantages of Single-Payer Systems

The case for single-payer rests on several compelling points. First, administrative simplicity translates to real cost savings. A study found that the administrative burden of health care in the United States was 27 percent of all national health expenditures, with the excess administrative cost of the private insurer system estimated at about $471 billion in 2012 compared to a single-payer system like Canada’s. That’s over $1 out of every $5 of total healthcare spending just going to paperwork, billing disputes, and insurance company profit and overhead before any patient receives care.

Universal coverage is another major advantage. In a properly functioning single-payer system, nobody goes bankrupt from medical bills, nobody delays care because they can’t afford it, and nobody loses coverage when they lose their job. The peace of mind that comes with knowing you’re covered regardless of employment status or pre-existing conditions is difficult to quantify but enormously valuable.

Single-payer systems also have significant negotiating power. When one entity is buying drugs and services for an entire nation, pharmaceutical companies and medical device manufacturers have much less leverage to charge whatever they want. This helps explain why prescription drug prices in other countries are often a fraction of prices in the U.S.

Disadvantages and Trade-offs

The critics of single-payer systems aren’t wrong about everything. Wait times are a genuine concern in some systems. When prices and overall budgets are tightly controlled, some countries experience longer waits for selected elective surgeries, imaging, or specialty visits, especially if investment lags demand.

In 2024, Canadian patients experienced a median wait time of 30 weeks between specialty referral and first treatment, up from 27.2 weeks in 2023, with rural areas facing even longer delays. For procedures like elective orthopedic surgery, patients wait an average of 39 weeks in Canada.

However, it’s crucial to understand that wait times are not a result of the single-payer system itself but of system management, as wait times vary significantly across different single-payer and social insurance systems. Many European countries with universal coverage don’t experience the same wait time issues that plague Canada.

The transition costs are also substantial. Moving from our current system to single-payer would disrupt a massive industry. Over fifteen percent of our economy is related to health care, with half spent by the private sector. Around 160 million Americans currently have insurance through their employers, and transitioning all of them to a government-run plan would be an enormous administrative and political challenge.

A large national payer can be slower to change benefit designs or adopt new payment models; shifting political majorities can affect funding levels and benefit generosity.

Taxes would need to increase significantly to fund such a system, though proponents argue this would be offset by the elimination of insurance premiums, deductibles, and co-pays. It’s essentially a question of whether you’d rather pay through taxes or through premiums—the money has to come from somewhere.

Advantages of America’s Mixed System

Our current system does have some genuine strengths. Innovation thrives in the American healthcare market. The profit motive, for all its flaws, does drive pharmaceutical research and medical device development. American medical schools and research institutions lead the world in many areas of medicine. Academic medical centers and specialty hospitals deliver advanced procedures and complex care that attract patients internationally.

The system also offers more choice for those who can afford it. If you have good insurance, you typically face shorter wait times for elective procedures and can often see specialists without lengthy delays. Americans with high-quality employer-sponsored coverage give their plans relatively high ratings.

Competition between providers can theoretically drive quality improvements, though this effect is often undermined by the complexity of the market and the difficulty consumers face in shopping for healthcare.

Disadvantages of the Current U.S. System

The most glaring problem is simple: The United States remains the only developed country without universal healthcare, and 30 million Americans remain uninsured despite gains under the Affordable Care Act, and many of these gains will soon be lost. Being uninsured in America isn’t just an inconvenience—it can be deadly. People delay care, skip medications, and avoid preventive screenings because of cost concerns.

The administrative complexity is staggering. Doctors spend enormous amounts of time dealing with insurance companies, prior authorizations, and billing disputes. Hospitals employ armies of billing specialists just to navigate the maze of different insurance plans, each with its own rules, formularies, and coverage determinations. U.S. administrative costs account for ~25% of all healthcare spending, among the highest in the world.

Medical bankruptcy is uniquely American. Even people with insurance can find themselves financially devastated by serious illness. High deductibles, surprise bills, and out-of-network charges create a minefield of potential financial catastrophe. Studies of U.S. bankruptcy filings over the past two decades have consistently found that medical bills and medical problems are a major factor in a large share of consumer bankruptcies. Recent summaries suggest that roughly two‑thirds of US personal bankruptcies involve medical expenses or illness-related income loss, and around 17% of adults with health care debt report declaring bankruptcy or losing a home because of that debt.

The system is also profoundly inequitable. Quality of care often depends more on your job, your income, and your zip code than on your medical needs. Out-of-pocket costs per capita have increased as compared to previous decades and the burden falls disproportionately on those least able to afford it.

What Europe Shows Us

The European experience demonstrates that there isn’t one “right” way to achieve universal coverage. The UK’s NHS, Germany’s sickness funds, and France’s hybrid system all manage to cover everyone at roughly half the per-capita cost of American healthcare. Universal Health Coverage exists in all European countries, with healthcare financing almost universally government managed, either directly through taxation or semi-directly through mandated and government-subsidized social health insurance.

They’ve accomplished this through various combinations of centralized negotiation of drug prices, global budgets for hospitals, strong primary care systems that serve as gatekeepers to more expensive specialist care, emphasis on preventive services, and regulation that prevents insurance companies from cherry-picking healthy patients.

Are these systems perfect? No. One of the major disadvantages of centralized healthcare systems is long wait lists to access non-urgent care, though Americans often wait as long or longer for routine primary care appointments as do patients in most universal-coverage countries. Many European countries are wrestling with funding challenges as populations age and expensive new treatments become available. But they’ve solved the fundamental problem that America hasn’t: they ensure everyone has access to healthcare without the risk of financial ruin.

The Path Forward?

The debate over healthcare in America often presents false choices. We don’t have to choose between Canadian-style single-payer and our current system—there are multiple models we could adapt. We could move toward a German-style system with heavily regulated non-profit insurers. We could create a robust public option that competes with private insurance. We could expand Medicare gradually by lowering the eligibility age over time.

What’s clear from international comparisons is that the status quo is unusually expensive and produces mediocre results. We’re paying premium prices for economy outcomes. Whether single-payer is the answer depends partly on your priorities. Do you value universal coverage and cost control more than unlimited choice? Are you willing to accept potentially longer wait times for non-urgent care in exchange for lower costs and universal access? How much do you trust government to manage a program this large?

These aren’t easy questions, and reasonable people disagree. But the evidence from Europe suggests that universal coverage at reasonable cost is achievable—it just requires us to make some choices about what we value most in a healthcare system.

Sources:

Centers for Medicare & Medicaid Services National Health Expenditure Data: https://www.cms.gov/data-research/statistics-trends-and-reports/national-health-expenditure-data/historical
Commonwealth Fund international comparisons: https://www.commonwealthfund.org/publications/issue-briefs/2023/jan/us-health-care-global-perspective-2022
Peterson-KFF Health System Tracker: https://www.healthsystemtracker.org/chart-collection/u-s-life-expectancy-compare-countries/
Wikipedia overview of single-payer systems: https://en.wikipedia.org/wiki/Single-payer_healthcare
Harvard Health discussion of single-payer: https://www.health.harvard.edu/blog/single-payer-healthcare-pluses-minuses-means-201606279835
BMC study on administrative costs: Referenced in Wikipedia article on single-payer healthcare
Fraser Institute wait times data: https://www.fraserinstitute.org/studies/waiting-your-turn-wait-times-for-health-care-in-canada-2024
Healthcare systems comparison (European models): https://www.healthcare-now.org/euhealthcare/

The Multitasking Myth

By John Turley

On December 20, 2025

In Commentary, Medicine

What’s Really Happening in Your Brain

You’re probably multitasking right now. Maybe you’re reading this with a podcast playing in the background, or you’ve got three browser tabs open and you’re checking your phone every few minutes. We all do it. We even brag about it on resumes: “Excellent multitasker!” But here’s the uncomfortable truth that neuroscience has been trying to tell us for years—what we call multitasking is mostly an illusion.

What People Actually Mean

When most people say they’re multitasking, they’re describing one of two scenarios. The first is doing multiple automatic activities simultaneously—like walking while talking, or listening to music while folding laundry. The second, and the one that gets more interesting, is rapidly switching attention between different demanding tasks—like answering emails while on a conference call, or texting while watching TV.

The distinction matters because our brains handle these situations very differently. Activities that have become automatic through practice don’t require much conscious attention. You can absolutely walk and chew gum at the same time because neither activity demands your prefrontal cortex’s full attention. But when both tasks require active thinking and decision-making? That’s where things get complicated.

The Brain’s Bottleneck

Here’s what neuroscience tells us: true multitasking—simultaneously processing multiple streams of complex information—is essentially impossible for the human brain. What feels like multitasking is actually rapid task-switching, and your brain pays a price every time it makes that switch.

The limitation comes from something researchers call the “response selection bottleneck.” When you’re performing tasks that require conscious thought, they all funnel through the same neural pathways in your prefrontal cortex. This region can only process one demanding task at a time, so when you think you’re doing two things at once, you’re really just toggling between them very quickly.

Studies using functional MRI brain imaging have shown what happens during this switching process. When people attempt to multitask, researchers observe reduced activity in the regions responsible for each individual task compared to when those tasks are done separately. Your brain literally can’t devote full processing power to both activities simultaneously.

The Switching Cost

Every time you switch from one task to another, there’s a cognitive cost. Your brain needs to disengage from the first task, shift attention, and then reorient to the new task. This happens so quickly—sometimes in tenths of a second—that we don’t consciously notice it. But those microseconds add up.

Sorry, but get ready for some doctor talk. When people switch tasks, imaging studies show increased activation in frontoparietal control and dorsal attention networks, especially in prefrontal regions (like the inferior frontal junction) and parietal cortex (such as intraparietal sulcus). This boosted activity reflects the brain dropping one task set, loading another into working memory, and re‑orienting attention—processes that consume time and neural resources.

Over time, practice can make specific tasks more automatic, reducing average activity in these control networks and allowing smoother coordination of tasks. However, even in trained multitaskers, studies still find evidence for serial queuing of operations in the multiple‑demand frontoparietal network, reinforcing the idea that consciously doing multiple demanding things “at once” is extremely limited.

Research from Stanford University found that people who regularly engage in heavy media multitasking actually perform worse at filtering out irrelevant information and switching between tasks than people who focus on one thing at a time. Essentially, chronic multitaskers become worse at the very thing they practice most.

Even when people train extensively, studies indicate they mainly become faster at switching and coordinating, not truly doing two demanding tasks at once. Experimental work using reaction‑time paradigms shows a reliable “switch cost”: when people change tasks, responses get slower and more error‑prone compared to staying with one task. This cost is one of the strongest signs that most human “multitasking” is serial switching under time pressure rather than genuine simultaneous processing.

The American Psychological Association reports that these mental blocks created by switching between tasks can cost up to 40% of productive time. Think about that for a minute—nearly half your work time potentially lost to the mechanics of jumping between activities.

The Attention Residue Problem

There’s another wrinkle that makes multitasking even less efficient. When you switch away from a task before completing it, part of your attention remains stuck on the unfinished work. Researchers call this “attention residue,” and it reduces your cognitive performance on the next task.

Sophie Leroy, a business professor at the University of Washington, demonstrated this effect in a series of studies. People who switched tasks performed significantly worse on the second task than people who finished the first task before moving on. The unfinished task keeps running in your mental background, using up cognitive resources you need for the new activity.

When “Multitasking” Actually Works

There are legitimate exceptions to the no-multitasking rule, but they’re more limited than most people think. You can successfully combine activities when at least one of them is so well-practiced that it’s become automatic—essentially requiring no conscious thought. You can listen to an audiobook while jogging because your body handles the running on autopilot.

Some research also suggests that certain types of background music or ambient noise can enhance performance on creative tasks, though this seems to work best when the music is familiar and lacks lyrics that compete with language-processing tasks.

Why We Keep Trying

If multitasking is so inefficient, why do we persist? Part of the answer lies in how it feels. Task-switching triggers the release of dopamine, the brain’s reward chemical. Every time you check your phone or switch to a new browser tab, you get a little neurochemical hit. It feels productive, even when it isn’t.

There’s also a cultural element. We live in an attention economy where being constantly connected and responsive feels mandatory. Focusing on one thing can feel like you’re missing out or falling behind, even though the research consistently shows that single-tasking produces better results faster.

It’s worth noting that research consistently shows this gap between perception and performance. People who think they are excellent multitaskers tend to be the worst at it.

The Bottom Line

The evidence is pretty clear: what we call multitasking is really task-switching, and it makes us slower and more error-prone at both activities. Your brain has a fundamental processing limitation that hasn’t changed despite our increasingly multi-screen world. The prefrontal cortex can only fully engage with one complex task at a time, and switching between tasks creates cognitive costs that add up to significant lost productivity and increased mistakes.

This doesn’t mean you should never listen to music while working or that walking while talking will melt your brain. But when you’re doing something that really matters—writing an important email, having a meaningful conversation, learning something new—giving it your full attention will always produce better results than splitting your focus.

A1c Without Diabetes: Context Matters As Much As The Number

By John Turley

On December 17, 2025

In Medicine

If you’ve had routine bloodwork lately, you might have noticed something called hemoglobin A1c (or HbA1c) on your results. For years, this test has been the gold standard for monitoring diabetes, but it’s increasingly also being used to assess metabolic health in people who don’t have diabetes. Let’s dig into what this number actually tells us and if lower is always better.

What A1c Actually Measures

Hemoglobin A1c reflects your average blood sugar levels over the past two to three months. When glucose circulates in your bloodstream, some of it sticks to hemoglobin—the oxygen-carrying protein in your red blood cells. The more glucose floating around, the more hemoglobin gets “glycated” (coated with sugar). Since red blood cells live about three months, your A1c percentage gives a rolling average of your blood sugar control. It does not capture individual spikes and dips in glucose, but it correlates reasonably well with overall glycemic exposure and is widely used to monitor diabetes control.

For non-diabetics, a normal A1c is generally considered below 5.7%. The prediabetes range sits between 5.7% and 6.4%, while 6.5% or higher on two separate tests typically indicates diabetes. Nondiabetic adults with A1c above about 6% are more likely to have impaired fasting glucose and other cardiometabolic risk factors than those with A1c around 5.2–5.3%.

These cutoffs represent points where research has shown increased risk for complications, but like most biological measurements, they exist on a spectrum rather than as hard dividing lines.

Even in non-diabetics, A1c can vary by genetics, age, ethnicity, iron levels, sleep quality, and stress—not just diet or exercise. That’s why one person may live at 5.2% with no effort, while another naturally runs 5.6%.

The Prediabetes Gray Zone

Here’s where things get interesting—and a bit complicated. Prediabetes affects roughly 98 million American adults, though most don’t know they have it. An A1c between 5.7% and 6.4% signals that your body’s relationship with glucose isn’t quite right. Maybe your cells are becoming resistant to insulin, or your pancreas isn’t producing insulin as efficiently as it once did. Prediabetes isn’t a disease so much as a metabolic warning sign. It means your body is starting to struggle with glucose regulation—often due to reduced insulin sensitivity, higher visceral fat, chronic stress, poor sleep, or genetics.

The crucial thing about prediabetes is that it’s not a benign waiting room before diabetes. Research shows that even in this intermediate range, you face elevated risks for cardiovascular disease, kidney problems, and nerve damage—though not to the same degree as someone with full-blown diabetes. It often coexists with other metabolic risk factors such as excess weight, dyslipidemia, and elevated blood pressure. A large study published in The Lancet found that people with A1c levels in the prediabetic range had a 15-20% increased risk of cardiovascular events compared to those with normal levels.

The good news? Prediabetes is often reversible. Lifestyle changes—particularly losing 5-7% of body weight through diet and exercise—can bring A1c levels back down. The Diabetes Prevention Program, a landmark study, showed that such interventions reduced the risk of developing diabetes by 58% over three years.

Should Non-Diabetics Aim Lower?

Now we arrive at the million-dollar question: if your A1c is already in the normal range (say, 5.3%), would driving it even lower—to 5.0% or 4.8%—provide additional health benefits?

The honest answer is: we don’t really know, but the evidence suggests probably not much.

Here’s what the research tells us. Population studies have found a continuous relationship between A1c levels and cardiovascular risk even within the normal range, meaning that someone with an A1c of 5.5% might have slightly higher risk than someone at 5.0%. However—and this is critical—this doesn’t necessarily mean that artificially lowering your A1c will reduce that risk. Correlation isn’t causation.

Your A1c reflects your overall metabolic health, dietary patterns, genetics, and lifestyle. Someone who naturally maintains an A1c of 5.0% because they exercise regularly, eat a balanced diet, and have favorable genetics probably has lower risk than someone at 5.5%. But that doesn’t mean the person at 5.5% should obsess over shaving off half a percentage point. Large cohort data suggest that the lowest risk band for nondiabetic adults is roughly an A1c around 5.0–5.6%; below about 5.0% the relationship between A1c and outcomes becomes more complex.

There’s a principle in medicine that “lower is better” but it often has limits. In diabetes treatment, pushing A1c too low can actually increase risks—particularly hypoglycemia (dangerously low blood sugar), which carries its own serious complications. The ACCORD trial, which studied intensive glucose lowering in people with Type 2 diabetes, had to be stopped early because the group targeting very low A1c levels had increased mortality. While this study involved diabetics using medications, it illustrates that extremely low glucose isn’t necessarily optimal.

If someone tries to force their A1c unusually low through extreme dieting, fasting, or intensive exercise, they can run into unintended effects such as fatigue and irritability, hormonal disruption, disordered eating patterns, and nutrient deficiencies. Importantly, extremely low A1c values can sometimes reflect anemia or other medical conditions, not superior health.

For non-diabetics with normal A1c levels, there’s no evidence that trying to push numbers lower through extreme dietary restriction or other interventions provides meaningful benefit. Your body is already handling glucose appropriately. The focus should be on maintaining that healthy state through sustainable lifestyle habits rather than chasing incremental improvements in a single biomarker. In practical terms, the benefit is less about the exact number (say 5.1 versus 4.8) and more about maintaining a metabolic profile that keeps A1c comfortably below the prediabetes threshold over the long term

What Actually Matters

Rather than fixating on squeezing every tenth of a point out of your A1c, the evidence supports a broader approach to metabolic health. Regular physical activity, maintaining a healthy weight, eating a diet rich in whole foods with plenty of fiber, getting adequate sleep, and managing stress all contribute to healthy glucose metabolism—and they bring countless other benefits beyond A1c.

It’s also worth noting that A1c isn’t perfect. Certain conditions—like anemia, chronic kidney disease, or hemoglobin variants—can make A1c readings inaccurate. Some people have A1c levels that don’t match what their continuous glucose monitors show, a phenomenon called “glycation gap.” A1c is a useful tool, but it’s one piece of a larger metabolic picture.

The bottom line? If your A1c is in the normal range, you’re doing well. Maintain the healthy habits that got you there rather than micromanaging the number itself. If you’re in the prediabetic range, you have a genuine opportunity to prevent diabetes through lifestyle changes, and bringing that number down has clear benefits. But for those already in the healthy zone, obsessing over fractional improvements likely won’t move the needle much on your actual health outcomes.

Understanding Parkinson’s Disease: From Diagnosis to Daily Living

By John Turley

On December 13, 2025

In Medicine, Uncategorized

When most people think of Parkinson’s disease, they picture the characteristic tremor—that involuntary shaking that has become almost synonymous with the condition. But the reality is far more complex than just one visible symptom. Let’s dig into what’s actually happening in the brain, how doctors figure out what’s going on, and what living with this condition really looks like.

What Causes Parkinson’s Disease?

Here’s where things get frustrating for researchers: despite decades of study, scientists still don’t know exactly what causes the nerve cells in the brain to die. I’m going to apologize in advance because I’m going to be using a lot of “doctor talk”—no way around it.

What we do know is that nerve cells (neurons) in the substantia nigra portion of the basal ganglia—an area of the brain controlling movement—become impaired or die, and these neurons normally produce dopamine, an important brain chemical. When these cells stop working properly, dopamine levels drop, and that’s when movement problems begin showing up.

But dopamine isn’t the whole story. People with Parkinson’s also lose nerve endings that produce norepinephrine, the main chemical messenger of the sympathetic nervous system, which helps explain why the disease affects so much more than just movement—things like blood pressure, digestion, and energy levels all take a hit.

Most Parkinson’s cases are idiopathic, meaning the cause is unknown, though contributing factors have been identified. Current thinking suggests a complicated mix of genetic and environmental factors. About 5% to 10% of cases begin before age 50, and these early-onset forms are often, though not always, inherited.

Some risk factors have emerged from research: age is the most significant, with about 1% of those over 65 and around 4.3% of those over 85 affected. Traumatic brain injury significantly increases risk, especially if recent, and repeated head injuries from contact sports can cause what’s called post-traumatic parkinsonism. Muhammad Ali is a classic example of this.

Exposure to pesticides and industrial chemicals has also been identified as a risk factor. Interestingly, large epidemiologic studies consistently show that people who smoke have a lower risk of being diagnosed with Parkinson’s disease than never‑smokers, although smoking is still strongly discouraged because of its many harmful health risks. Large cohort studies in the U.S. and Europe generally find no direct association between alcohol consumption and Parkinson’s disease. A few observational studies show that moderate drinkers have slightly lower Parkinson’s rates. However, researchers believe this may be due to reverse causation (people in early or undiagnosed stages often reduce drinking because of GI or mood changes) and lifestyle confounders (moderate drinkers may differ in socioeconomic status, diet, or activity level). So, the “protective” effect is considered speculative, not causal.

The Symptoms: More Than Just Shaking

The hallmark movement symptoms—what doctors call “motor symptoms”—are what usually bring people to the doctor. Slowed movements, called bradykinesia, is required for a Parkinson’s diagnosis. People describe it as muscle weakness, though it’s really about control, not strength. The classic tremor, stiffness, and balance problems round out the main movement issues. Patients frequently show reduced arm swing, shuffling gait, difficulty initiating movement or turning, masked facial expression, decreased blinking, and soft or monotone speech.

But here’s what often surprises people: many individuals later diagnosed with Parkinson’s notice that prior to experiencing stiffness and tremor, they had sleep problems, constipation, loss of smell, and restless legs. These “prodromal symptoms” can show up years before the movement problems become obvious. Other early signs include mood disorders like anxiety and depression.

The cognitive side deserves attention too. Some people experience changes in cognitive function, including problems with memory, attention, and the ability to plan and accomplish tasks, though hard to pin down due to concurrence with age related memory problems, 20% at the time of diagnosis is a commonly cited number. More contested is how many develop Parkinson’s dementia, with estimates ranging from 20% all the way to 85%.

How Doctors Make the Diagnosis

Here’s something that might surprise you: there are currently no blood or laboratory tests to diagnose non-genetic cases of Parkinson’s. The standard diagnosis is clinical, meaning there’s no test that can give a conclusive result—certain physical symptoms need to be present.

Doctors typically diagnose Parkinson’s by taking a detailed medical history and performing a neurological examination. If symptoms improve after starting medication, that’s another indicator that the person has Parkinson’s.

There are some imaging tools available. The FDA approved an imaging scan called the DaTscan in 2011, which allows doctors to see detailed pictures of the brain’s dopamine system using a radioactive drug and SPECT scanner. But this scan can’t definitively diagnose Parkinson’s though it helps rule out conditions that mimic it. A hallmark of Parkinson’s is the buildup of misfolded alpha-synuclein proteins (Lewy bodies) inside neurons. Whether this is a cause, an effect, or both is still under study—this part of the science remains somewhat speculative.

Recently, researchers developed something more promising: the alpha-synuclein seeding amplification assay can detect abnormal alpha-synuclein in spinal fluid and may detect Parkinson’s in people who haven’t been diagnosed yet. The catch? It requires a spinal tap and isn’t widely available, though scientists are working on blood and saliva tests.

The early diagnostic challenge is real. Many disorders can cause similar symptoms, and people with Parkinson’s-like symptoms from other causes are sometimes said to have parkinsonism, which includes conditions like multiple system atrophy and Lewy body dementia that require different treatments.

What to Expect: The Prognosis

Let’s address the big question: how does Parkinson’s affect life expectancy? The news here is better than you might think. The average life expectancy of a person with Parkinson’s is generally the same as for someone without the disease.

More specifically, average life expectancy has increased by about 55% since 1967, rising to more than 14.5 years from diagnosis. Modern treatments have made a huge difference. Research indicates that those with Parkinson’s and normal cognitive function appear to have a largely normal life expectancy.

That said, timing matters. Research from 2020 suggests that people who receive a diagnosis before age 70 usually experience a greater reduction in life expectancy, and males with Parkinson’s may have a greater reduction in life expectancy than females.

The disease is progressive, meaning it gets worse over time, but symptoms and progression vary from person to person, and neither you nor your doctor can predict which symptoms you’ll get, when, or how severe they’ll be. The tremor-dominant type usually has a more favorable prognosis than the hypokinetic type.

What actually causes death in advanced Parkinson’s? Advanced symptoms can cause falls, pressure ulcers, swallowing difficulties and general frailty, all of which are linked to death. Aspiration pneumonia—when you inhale food or liquid into the lungs—is the leading cause of death for people with Parkinson’s.

Managing the Disease

Currently, there’s no cure for Parkinson’s, but medications or surgery can improve many of the movement symptoms.

The gold standard medication is levodopa (often combined with carbidopa as Sinemet). Healthcare providers use levodopa cautiously and they commonly combine it with other medications to keep your body from processing it before it enters your brain. This helps avoid side effects like nausea, vomiting, and low blood pressure when standing up. The tricky part? Over time, the way your body uses levodopa changes, and it can lose effectiveness.

Beyond levodopa, doctors use MAO-B inhibitors and dopamine agonists. As the disease progresses, these medications become less effective and may cause involuntary muscle movements. When drugs stop working well, there are surgical options to treat severe motor symptoms.

The main surgical treatment today is called deep brain stimulation (DBS). It is the most important therapeutic advancement since the development of levodopa, and it’s been FDA-approved since the late 1990s A surgeon places thin metal wires called electrodes into one or both sides of the brain, in specific areas that control movement. A second procedure implants an impulse generator battery under the collarbone or in the abdomen. It is similar to a heart pacemaker and about the size of a stopwatch, this device delivers electrical stimulation to those targeted brain areas.

A new treatment that is being used is focused ultrasound. Guided by MRI, high-intensity, inaudible sound waves are emitted into the brain, and where these waves cross, they create high energy that destroys a very specific area connected to tremor. It’s considered non-invasive and the FDA has approved it for Parkinson’s tremor that doesn’t respond to medications.

Don’t underestimate lifestyle interventions either. Physical therapy can improve balance and address muscle stiffness, and regular exercise improves strength, flexibility, and balance. Eating a balanced diet helps—drinking plenty of water and eating enough fiber reduces constipation, while omega-3 fats and magnesium may boost cognition and help with anxiety.

Parkinson’s disease sits at the intersection of aging, genetics, environment, and biology. Diagnosis is clinical, progression is gradual and variable, and treatment has become increasingly sophisticated. While it remains incurable, early diagnosis, personalized medication plans, targeted therapies like DBS, and consistent exercise allow many people to maintain meaningful independence for years.

The key message from specialists? Treatment makes a major difference in keeping symptoms from having worse effects, and adjustments to medications and dosages can hugely impact how Parkinson’s affects your life.

The Correlation Mirage: How Good Intentions Go Wrong in Health Debates

By John Turley

On December 8, 2025

In Commentary, Medicine

Understanding the Basics

Here’s the fundamental problem: just because two things happen together doesn’t mean one caused the other. When we say two variables are “correlated,” we’re simply observing that they move in tandem—when one goes up, the other tends to go up (or down). Causation, on the other hand, means that a change in one variable directly causes a change in the other. Think of correlation as a suspicious coincidence, while causation is a proven relationship with a clear mechanism.

The tricky part is that our brains are pattern-seeking machines. We evolved to spot connections quickly because that helped our ancestors survive. If you ate those red berries and got sick, better to assume the berries caused it rather than to wait around for a controlled study. But this mental shortcut can seriously mislead us in the modern world, especially when it comes to complex health issues.

Classic Examples That Illustrate the Problem

Let me give you some examples that show how ridiculous this confusion can get when we’re not careful. There’s a famous correlation between ice cream sales and drowning—both increase during summer months, but ice cream isn’t causing drowning. The real driver is warmer weather, which leads people to both buy more ice cream and to spend more time at beaches or swimming pools where drowning might happen. This is what researchers call a “confounding variable”—a third factor that influences both things you’re measuring.

Here’s another head-scratcher: there’s a correlation between the number of master’s degrees awarded and box office revenue. Does getting more education somehow boost movie sales? Of course not. This is what we call a spurious correlation—a completely coincidental relationship that exists in the data but has no meaningful connection in reality.

Here’s good news for us coffee drinkers. For years, studies suggested a correlation between heavy coffee drinking and heart disease. Later research found the real issue: heavy coffee drinkers were also more likely to smoke. Once smoking was controlled for, coffee itself did not increase heart risk.

Perhaps the most amusing example is the correlation between stork populations and birth rates in Germany and Denmark spanning decades. As the stork population fluctuated, so did the number of newborns. Now, you could construct a “Theory of the Stork” claiming that storks deliver babies, but the real explanation probably involves other variables like weather patterns, urbanization, or environmental developments that affected both populations.

The medical field offers more serious examples. You observe a strong correlation between exercise and skin cancer cases—people who exercise more seem to get skin cancer at higher rates. Without digging deeper, you might panic and conclude that exercise somehow causes cancer. But the actual explanation is far more mundane: people who exercise more tend to spend more time outdoors in the sun, which increases their UV exposure. The confounding variable here is sun exposure, not the exercise itself.

The Vaccine-Autism Controversy: A Cautionary Tale

Now let’s talk about one of the most damaging correlation-causation confusions in recent medical history: the claim that vaccines cause autism. Many childhood vaccines are administered at the same ages when numerous developmental conditions first become noticeable—including autism, seizure disorders, and certain metabolic or genetic issues. This is a textbook case of how mistaking correlation for causation can have real-world consequences.

The whole mess started in 1998 when Andrew Wakefield, a gastroenterologist at London’s Royal Free Hospital, published a paper in The Lancet describing 12 children, eight of whom were reported as having developed autism after receiving the MMR vaccine. Here’s the thing: this wasn’t even a proper study that could establish causation. It was described as a consecutive case series with no control group or control period—it was simply a description that couldn’t tell you whether one thing causes another.

But why did this idea catch fire so dramatically? The timing created a perfect storm for correlation-causation confusion. Autism becomes apparent early in childhood, around the same time children receive many vaccines and there will be a temporal relationship by chance alone. Parents naturally searched for explanations, noticed the temporal proximity, and drew what seemed like an obvious conclusion.

The scientific community took these concerns seriously and conducted extensive research. Despite overwhelming data demonstrating that there is no link between vaccines and autism, many parents remain hesitant to immunize their children because of the alleged association. Study after study found no connection. A study of over 500,000 children in Denmark, published in The New England Journal of Medicine in 2002 found no relationship between autism and MMR as did a subsequent Danish study published in 2019. In April 2015, JAMA published a large study analyzing health records of over 95,000 children, including about 2,000 who were at risk for autism because they had a sibling already diagnosed. It confirmed that the MMR vaccine did not increase the risk for autism spectrum disorder.

The original Wakefield study eventually collapsed under scrutiny. The Lancet retracted the article, and Wakefield was found guilty of deliberate fraud—he picked and chose data that suited his case and falsified facts. Wakefield lost his license to practice medicine after being sanctioned by scientific bodies. But by then, the damage was done.

Here’s the correlation-causation issue in stark terms: the prevalence of autism has increased over time, which researchers and healthcare professionals explain is likely due to multiple factors, including people becoming more aware of autism, improved screening, and updated and expanded diagnostic criteria to include other conditions on the autism spectrum. Meanwhile, immunizations have increased and have dramatically reduced the incidence of vaccine-preventable diseases. These two trends—increasing autism diagnoses and increasing vaccination rates—happened to occur during the same historical period, creating an illusory correlation.

The real causes of autism are complex. There is no single root cause; a combination of influences is likely involved, including certain genetic syndromes, genetic changes affecting cell function, and environmental influences such as premature birth, older parents, and illness during pregnancy. Vaccines simply aren’t part of that picture.

Other Health-Related Confusion

The vaccine-autism controversy isn’t the only place where correlation-causation confusion causes problems in health contexts. Let me give you a few more examples that show how pervasive this issue is and how difficult it can be to distinguish between correlation and causation.

Consider the relationship between diet and health outcomes. The amount of sodium a person gets in their diet is closely correlated to the total calories they eat—in other words, the more a person eats, the more sodium they’re likely to take in, and eating a lot of calories often leads to obesity. Both obesity and high-sodium diets are believed to contribute to high blood pressure. So, what’s the primary driver? Is it sodium, excess calories, or obesity? These are exactly the kinds of questions researchers must carefully untangle.

Here’s another tricky one: research has shown a correlation between antibiotic use in children and increased risk of obesity, with greater antibiotic use associated with higher obesity risk, particularly for children with four or more exposures. But this correlation alone doesn’t tell us whether antibiotics cause obesity. There could be multiple explanations: perhaps children who need frequent antibiotics have other health issues that predispose them to weight gain, or perhaps the infections themselves (not the antibiotics) are the real issue, or maybe it’s actually a disruption of gut bacteria that matters. Without understanding the exact physiological mechanism, we can’t design effective interventions.

Similarly, increased BMI seems to be associated with an increased risk of several cancers in adults. But it would be erroneous to conclude that simply being overweight directly causes cancer. Socioeconomic factors, environmental toxins, access to healthcare, lifestyle differences, physical activity levels, and diet all intertwine in complex ways. Some people may face multiple risk factors simultaneously, making it difficult to isolate which factors are most significant.

When cell phones first became widely used, there was an increasing concern that radiation from the cell phones was causing brain cancer. Brain cancer rates have remained stable for decades despite exponential increases in cell-phone use—strong evidence against a causal relationship.

Beyond Statistics

The stakes here go way beyond academic accuracy. When people confuse correlation with causation in health contexts, they make decisions that can harm themselves and others. The 2017 measles epidemic in Minnesota’s Somali community was in no small measure fomented by Wakefield—he didn’t fade away quietly. He and other anti-vaxers repeatedly proselytized to the community, leading to an approximately 45% reduction in vaccination. At the same time there was an increase in autism diagnoses. Think about that: vaccination rates dropped, yet autism diagnoses continued to rise—the exact opposite of what you’d expect if vaccines caused autism. A word of caution: this is an observation, not a carefully controlled study.

The problem extends to how we evaluate new treatments and risk factors. In clinical medicine, there are treatment protocols in use that are not supported by randomized controlled trials. There are risk factors that have been associated with various diseases where it’s difficult to know for certain if they are actually contributing causes. This uncertainty creates space for misunderstanding.

How Scientists Establish Causation

So, how do researchers move from observing a correlation to proving causation? They look for several key elements. These include: a stronger association between variables (which is more suggestive of cause and effect than a weaker one), proper temporality (the alleged effect must follow the suspected cause), a dose-response relationship (where increasing exposure leads to proportionally greater effects), and a biologically plausible mechanism of action.

The gold standard is the randomized controlled trial, where researchers can carefully control for confounding variables by randomly assigning people to treatment and control groups. For ethical reasons, there are limits to controlled studies—it wouldn’t be appropriate to use two comparable groups and have one undergo a harmful activity while the other does not. That’s why we often rely on observational studies combined with careful statistical methods to rule out alternative explanations.

The Bottom Line

Understanding the difference between correlation and causation isn’t just an academic exercise—it’s a critical thinking skill that helps you navigate health claims, news stories, and medical decisions. The vaccine-autism controversy shows how dangerous it can be when we mistake coincidental timing for causal relationships, especially when those misunderstandings spread through communities and lead to preventable disease outbreaks.

The key takeaway? When you see two things happening together, your brain will want to assume one caused the other. Resist that urge. Ask yourself: could there be a third factor driving both? Could the timing just be coincidental? Is there a clear, testable mechanism that would explain how one causes the other? These questions can help you separate meaningful connections from statistical coincidences—and potentially save you from making poor health decisions based on faulty reasoning.

Understanding Herd Immunity

By John Turley

On November 15, 2025

In Medicine

Your Community’s Shield Against Disease

Picture your community as a fortress. The stronger the walls and the more guards on duty, the harder it becomes for invaders to breach the defenses. Herd immunity works similarly—it’s your community’s invisible shield against infectious diseases, and vaccination is the primary way we build and maintain that protection.

Initial observations of herd immunity arose from livestock studies in the early twentieth century. Farmers noticed that once most animals in a herd recovered from a disease, future outbreaks diminished or disappeared altogether. Public health scientists later confirmed that this same principle applies to humans.

What Is Herd Immunity?

Herd immunity means that enough people in a group or area have achieved immunity against a virus or other infectious agent so that it becomes very difficult for the infection to spread. When a critical proportion of the population becomes immune, called the herd immunity threshold, the disease may no longer persist in the population, ceasing to be endemic.

Think of it like a firebreak in a forest. If enough trees have already been burned (past infection) or treated with flame retardant (vaccination), the fire has a harder time jumping from tree to tree. Similarly, with herd immunity, the chain of transmission is disrupted.

Individuals who are immune to a specific disease act as a barrier to the spread of disease, slowing or preventing the transmission of disease to others. This protection can come from two main sources: surviving a natural infection or receiving vaccines. However, vaccination is by far the safer and more reliable path to immunity.

The Math Behind Community Protection

The magic number for herd immunity isn’t the same for every disease—it depends on how contagious the illness is. Scientists use something called the basic reproduction number (R₀) to figure this out. For measles, one of the most contagious diseases, (R₀=15), this means 1 – (1/15) = 1 – 0.067 = 0.933. Measles herd immunity requires 93% of the population to be immune, while polio—less contagious—requires 80%.

For COVID-19, the target has been a moving one. At the start of the pandemic, researchers thought that having 60% to 70% of the people in the world immunized through vaccination or infection would equal the level of herd immunity needed for COVID-19. However, the contagiousness of the delta and omicron variants has made researchers rethink that number. Now that number could be as high as 85%.

Protecting the Most Vulnerable

Here’s where herd immunity becomes truly meaningful: it’s not just about personal protection—it’s about creating a safety net for those who need it most. Herd immunity gives protection to vulnerable people such as newborn babies, elderly people and those who are too sick to be vaccinated. In every community, you will find individuals in these categories, making herd immunity that much more important.

Consider these community members who depend on herd immunity:

– Newborns who are too young to receive certain vaccines

– People undergoing cancer treatment whose immune systems are compromised

– Elderly individuals whose immune responses may be weaker

– Those with autoimmune diseases who cannot safely receive live vaccines

– People with severe allergies to vaccine components

These people then depend on others getting vaccinated to be indirectly protected by them. When vaccination rates drop in a community, these vulnerable populations face the greatest risk.

Vaccination: The Cornerstone of Herd Immunity

While natural infection can provide immunity, vaccination is the only viable path to herd immunity for most diseases. The alternative—letting diseases spread naturally—comes with devastating costs. Achieving herd immunity, the ‘natural’ way would mean that many people would die and many others get ill and some seriously ill.

Vaccines have transformed herd immunity from a risky process—one that relied on dangerous natural infection—into a safe and reliable public health strategy. When people are vaccinated, they receive a controlled stimulus that trains their immune systems to recognize and fight particular pathogens, without causing the disease itself. Widespread vaccination reduces the pool of susceptible hosts, “starving” the disease of opportunities to spread.

Real-world examples demonstrate vaccination’s power. In 2000, measles was declared defeated in the U.S. However, in 2019, a surge of new cases was recorded. This occurred as a result of the declining vaccination rates, showing the importance of vaccinations and their impact on herd immunity.

The success stories of vaccination are impressive: Global vaccination campaigns have eradicated smallpox from the planet, and they have eliminated polio from almost all countries in the world.

A Historical Speculation: What If We Had Vaccines in the past?

*Note: The following section involves speculation based on historical analysis.

The 1918 influenza pandemic, often called the Spanish flu, killed an estimated 50 million people worldwide—more than World War I. The H1N1 influenza pandemic that swept across the world from 1918 to 1919, sometimes called “the mother of all pandemics”, involved a particularly virulent new strain of the influenza A virus. The 1918 pandemic is estimated to have infected 500 million people worldwide.

Had a vaccine been available—and administered on a global scale—herd immunity might have dramatically altered the pandemic’s trajectory. Even 50–60% coverage could have slowed transmission enough to flatten the curve, sparing millions of lives. Hospitals, already overwhelmed, might have had more capacity to care for the sick.

Another instructive example is smallpox, which killed an estimated 300 million people in the 20th century alone. Historically, populations never exposed to smallpox—such as indigenous communities in the New World—suffered catastrophic losses, sometimes as high as 90% when the virus first arrived. European societies, by contrast, had some community immunity from years of prior exposure, but still suffered mortality rates as high as 25%.

Once the smallpox vaccine became widely used, herd immunity did its work so effectively that the disease was eradicated in 1980—the only human disease to be eliminated globally. This success story underscores the potential power herd immunity might have had against earlier plagues.

In the 1940s and 1950s, polio terrified parents across the United States. Summer outbreaks paralyzed thousands of children each year. Once the Salk and Sabin vaccines became available, vaccination campaigns rapidly built herd immunity. Within a few decades, polio was virtually eliminated in the U.S. and reduced worldwide by over 99%. Without herd immunity, the virus would still be circulating widely today.

The Reality Check: Why Herd Immunity Isn’t Always Achievable

Modern societies are paradoxically both more capable and more vulnerable when it comes to herd immunity. Global travel means diseases can spread between continents in hours. Vaccine hesitancy, fueled by misinformation, creates gaps in immunity. At the same time, scientific advances allow us to develop vaccines faster than ever—COVID-19 vaccines were available within a year of the virus’s emergence.

The COVID-19 pandemic also revealed the complexity of herd immunity. High transmission rates, evolving variants, and waning immunity made it nearly impossible to reach a stable herd immunity threshold. Instead, vaccines reduced severity and death, while natural infections layered additional immunity in populations. The lesson: herd immunity isn’t always permanent or perfect, but even partial protection can save countless lives.

This doesn’t mean vaccination is pointless—far from it. Even when herd immunity isn’t achievable, vaccination still provides crucial individual protection and reduces the overall burden of disease in communities.

Your Role in Community Protection

Herd immunity is one of our best tools for the prevention of infectious diseases, but it is a tool that must be continuously sharpened.

Understanding herd immunity helps us see vaccination not just as a personal choice, but as a community responsibility. Every person who gets vaccinated contributes to the collective shield that protects the most vulnerable members of our communities. It is a story about interdependence.

While the concept can seem abstract, its effects are concrete and measurable. When vaccination rates remain high, diseases that once terrorized communities become rare memories. When they drop, we see the return of preventable illnesses and, tragically, preventable deaths.

The next time you roll up your sleeve for a vaccination, remember you’re not just protecting yourself—you’re helping to maintain your community’s invisible fortress against disease.

This post reflects current scientific understanding of herd immunity and vaccination. For specific medical advice, always consult with a healthcare professional.

Smartphones, Smartwatches & Wearables for Seniors

By John Turley

On November 12, 2025

In Medicine

A Simple Guide to What Helps—and What’s Just Noise

If you’re over 60 and trying to figure out whether a smartphone, smartwatch, or wearable can genuinely make life healthier—or you’re helping a spouse or parent decide—you’re not alone. A lot of people feel overwhelmed by all the features, apps, alerts, and promises.

The good news: some of this tech actually helps. It won’t replace your doctor, but it can flag early problems, keep you safer at home, and make it easier for your family or care team to stay in the loop. The trick is knowing what’s useful and what’s just hype.

Let’s walk through it in plain English.

Why This Stuff Matters Now

Ten years ago, the idea that a watch could detect a fall or an irregular heartbeat felt like science fiction. Today, it’s routine. About a third of adults over 50 now use smartwatches or other wearables—and the number keeps rising.

For many older adults, these devices have quietly become part of the “safety net” that helps them stay independent.

How Smartphones Actually Help Your Health

1. Keeping Medications on Track

If you’ve ever forgotten a pill—or doubled a dose—you’re in good company. Medication mix-ups are incredibly common.

Apps like:

Medisafe – shows pill images, keeps a schedule, and even sends caregiver alerts.
Apple’s Medications app – built right into iPhones and Apple Watches.
CareClinic – tracks meds, moods, blood pressure, and symptoms in one place.

Studies from the National Library of Medicine show people using reminder apps stick to their meds far better than those who don’t.

2. Telemedicine That Actually Works

Telehealth isn’t a pandemic fad anymore—it’s now a standard part of care. Apps like Walmart Health Virtual Care or Heal let you talk to a clinician on video, sometimes even with Medicare coverage. Many can pull in data from wearables so your doctor gets a bigger picture than just your office visit.

3. Everyday Tools for Wellness

Your phone can track blood pressure, sleep, relaxation, and even your medical records.

Qardio for blood pressure and weight
Insight Timer for stress and sleep
My Medical for storing labs and appointment notes

Simple but surprisingly useful.

Smartwatches: What They Really Do Well

Modern smartwatches are basically mini health monitors. Not perfect—but often helpful.

The genuinely useful features

Irregular heartbeat detection (A-fib alerts). Apple’s A-fib notification is FDA-cleared and backed by a huge 419,000-person study.
Fall detection. If you take a hard fall and don’t respond, the watch can call 911.
Walking steadiness alerts. Your phone can notice changes in your balance.
Sleep tracking. Good for patterns—not a medical diagnosis.
Blood oxygen trends. Not perfect, but another piece of data.

Devices seniors tend to like

Apple Watch Series 9 / Ultra 2
Samsung Galaxy Watch7
Medical alert watches (like Medical Guardian or Bay Alarm), which keep things simple and focus on emergency features.

Continuous Glucose Monitors (CGM): A Game Changer

If you or a loved one has diabetes, CGMs may be the single most meaningful wearable health tool available.

They sit on your arm or abdomen and send glucose numbers to your phone every few minutes. No more finger sticks. No guessing. No surprises.

Why seniors like them

Far fewer finger pricks
Alerts for highs or lows (can literally prevent emergencies)
Better long-term glucose control
Optional caregiver alerts

Top CGM options

Dexcom G7 – Medicare-covered for many users
FreeStyle Libre 3 – small, simple, affordable
Medtronic Guardian Connect – syncs with insulin pumps

In 2023, Medicare expanded coverage, so more seniors now qualify.

Speculation: non-invasive glucose sensors (no needles at all) are being tested, but none are FDA-approved yet. Expect progress in the next few years.

Other Wearables That Actually Help

Not everything is a watch:

KardiaMobile 6L – a pocket-sized, FDA-approved ECG in 30 seconds
Tango Belt – a wearable “airbag” that inflates during a fall
Hero Health – a smart pill dispenser that takes the guesswork out of meds

These tend to be more practical than trendy.

How to Choose: Start with Your Goal

Instead of shopping features, pick the problem you’re trying to solve:

Worried about falls? Get a watch with fall detection.
Blood pressure issues? Pair your phone with a good upper-arm cuff.
Managing diabetes? Ask your doctor about CGM eligibility.
Heart rhythm concerns? Add a handheld ECG like Kardia.

And make sure the device is easy to share with family or clinicians. Apple’s Health Sharing is especially simple.

Remote Patient Monitoring (RPM)

This is where your doctor gets readings from your home devices automatically. Medicare even pays for it. It can catch early issues—like rising blood pressure—before they turn into bigger problems.

Just be aware not every clinic uses it yet.

Privacy: A Quick Reality Check

Most people assume health apps follow HIPAA. Many don’t.

HIPAA covers your doctor—not your app.
The FTC now requires some health apps to notify you of breaches.
Always review privacy policies to see who gets your data. Not fun, but necessary.

What Wearables Don’t Do Well

Here’s where things get messy:

Heart rate sensors can misread darker skin tones, tattoos, or movement.
SpO₂ readings can vary widely—enough that the FDA has issued warnings.
Sleep trackers estimate, they don’t diagnose.
Step counts vary by 10–30% depending on brand.

Think of wearables as “trends over time,” not medical tests.

Downsides to Keep in Mind

A few honest drawbacks:

Daily or near-daily charging
Subscription fees that creep up
Too many alerts (which most people eventually shut off)
Physical challenges like tiny text, small buttons, stiff bands
Data that doesn’t always sync with your doctor’s record
False reassurance (“My watch didn’t alert, so I’m fine”)

None of these are dealbreakers—but they’re worth knowing.

Where This Is All Going

Wearable tech will keep getting smaller and more accurate: rings, adhesive patches, even hearing aids that monitor your vitals.

Prediction (speculation): Within a few years, AI will connect your meds, sleep, glucose, heart data, and activity into simple daily guidance you can actually use. It’s not quite here yet, but it’s coming.

The Bottom Line

Smartphones and wearables can genuinely improve health and independence—but only if you choose based on your real needs. You don’t need every bell and whistle.

Start small.
Pick one goal.
Choose one device that helps with that goal.

Sometimes a simple fall-detection watch or a glucose sensor does far more good than the fanciest new feature. Used wisely, these tools give seniors—and their families—more safety, more independence, and more peace of mind.

The Real Enemy of the Revolution: Disease

By John Turley

On October 23, 2025

In History, Medicine

When you think about the American Revolution, you probably picture dramatic battles like Bunker Hill or the crossing of the Delaware. But here’s something that might surprise you: the biggest killer during the war wasn’t British muskets—it was disease. And it’s not even close.

The Numbers Tell a Grim Story

Let’s talk numbers for a second. On the American side, about 6,800 soldiers died from battlefield wounds. Sounds terrible, right? Well, disease killed an estimated 17,000 to 20,000. That’s roughly three times as many. The British and their Hessian allies faced similar odds: around 7,000 combat deaths versus 15,000 to 25,000 disease deaths.

Think about that for a moment. You were actually safer charging into battle than hanging around camp. In some regiments, disease wiped out more than a third of the troops before they even saw their first fight.

Why Was Disease So Deadly?

Picture yourself in a Revolutionary War military camp. Hundreds of men crammed together in makeshift shelters, no running water, primitive latrines dug too close to where everyone lives, and basically zero understanding of what we’d call “germ theory” today. It’s a perfect storm for infectious disease.

The big killers were:

Smallpox was the heavyweight champion of camp diseases. This virus killed about 30% of people it infected and spread like wildfire through packed military camps. Soldiers tried to protect themselves through a risky practice called inoculation—basically giving themselves a mild case of smallpox on purpose by rubbing infected pus into cuts on their skin. Without proper quarantine procedures, though, this sometimes made outbreaks worse instead of better.

Typhus (called “camp fever” back then) spread through lice and fleas. If you’ve ever been to a prolonged camping trip and felt gross after a few days, imagine that times a hundred. Soldiers lived in the same clothes for weeks, rarely bathed, and the parasites just had a field day. The fever, headaches, and diarrhea that came with typhus made it one of the most dreaded camp diseases.

Dysentery (charmingly nicknamed “bloody flux”) came from contaminated water and poor sanitation. When your latrine is 20 feet from your water source and you don’t understand how disease spreads, this becomes pretty much inevitable. The severe diarrhea weakened soldiers to the point where many couldn’t fight even if they wanted to and it made them even more susceptible to other diseases.

Malaria was especially important in the South, where mosquitoes thrived in the humid climate. This one actually played a fascinating role in how the war ended—but more on that in a bit.

When Disease Changed Everything

The 1776 invasion of Canada was a disaster largely because of smallpox. Out of 3,200 American soldiers in the Quebec campaign, 1,200 fell sick. You can’t mount much of an offensive when more than a third of your army is flat on their backs with fever. Similarly, during the siege of Boston, Washington couldn’t effectively engage the British because so many of his troops were sick with smallpox. These weren’t just setbacks—they were strategic catastrophes.

This is what pushed George Washington to make one of his boldest decisions in 1777: he ordered a mass inoculation of the Continental Army. This was controversial and dangerous at the time, but it worked. Washington had survived smallpox himself as a young man, so he understood both the risks and the benefits. The inoculation program probably saved the army from complete collapse.

Medical “Treatment” Was Often Worse Than Nothing

Here’s where things get really grim. Eighteenth-century medicine was basically medieval. Doctors believed in “balancing the humors” through bloodletting—literally draining blood from already weakened soldiers. They also gave powerful laxatives to people who were already suffering from diarrhea. Yeah, let that sink in.

Pain relief meant opium-based drinks or just straight alcohol. Some doctors used herbal remedies, but results were inconsistent at best. Quinine helped with malaria, though nobody really understood why. Mostly, if you got seriously sick, your survival came down to luck and a strong constitution.

Valley Forge: The Turning Point

Valley Forge is famous for being a brutal winter encampment, and disease was a huge part of why it was so terrible. Scabies left nearly half the troops unable to serve. Dysentery and camp fever killed somewhere between 1,700 and 2,000 soldiers during that single winter—and remember, these weren’t battle casualties. These men died from preventable diseases in what was supposed to be a safe encampment.

But Valley Forge taught the Continental Army a crucial lesson. After that nightmare winter, military leaders started taking sanitation seriously. They began focusing on camp hygiene, protecting water supplies, placing latrines away from living areas, and making sure soldiers could bathe and wash their clothes and bedding.

Baron von Steuben is famous for teaching the Continental Army how to march and drill, but he also deserves credit for implementing serious sanitation reforms. These changes helped prevent future disease outbreaks and kept the army functional for the rest of the war.

The Secret Weapon at Yorktown

Here’s one of my favorite historical details: mosquitoes may have helped win American independence. At Yorktown, roughly 30% of Cornwallis’s British army was knocked out by malaria and other diseases during the siege. The British commander was trying to hold off the American and French forces while also dealing with the fact that almost a third of his troops were too sick to fight.

Many American soldiers from the southern colonies had grown up with malaria and had some partial immunity. The British? Not so much. Some historians even think Cornwallis himself might have been suffering from malaria, which could have affected his decision-making. His second-in-command, Brigadier General Charles O’Hara, was definitely seriously ill during the siege. Fighting a war while you can barely stand is a pretty significant handicap.

The Bigger Picture

The American Revolution shows us something important: wars aren’t just won on battlefields. They’re won by the side that can keep its soldiers alive and healthy. Disease shaped strategic decisions, determined the outcomes of campaigns, and killed far more men than any British regiment ever did.

Washington’s decision to inoculate the army was genuinely revolutionary (pun intended). It showed a willingness to embrace controversial medical practices for the greater good. The sanitation reforms that came out of Valley Forge laid groundwork for modern military medicine and influenced public health policies in the new United States.

So next time someone mentions the American Revolution, remember: while we celebrate the military victories, one of the most important battles was fought against an enemy you couldn’t see—and for most of the war, nobody really knew how to fight it.

The casualty figures and major disease outbreaks are well-documented in historical records. The specific percentages and numbers are estimates based on historical research, as precise record-keeping was limited during this period. The overall narrative about disease being the primary cause of death is strongly supported by multiple historical sources.

Home Safety Checklist for Senior Citizens

By John Turley

On October 9, 2025

In Medicine

Creating a safe home environment becomes increasingly important as we age. Here’s a comprehensive checklist organized by key areas to help seniors and their families identify potential hazards and make practical improvements.

Fall Prevention (General)

Falls are the leading cause of injury among older adults, accounting for over 3 million emergency department visits annually. Here’s what to address:

Remove or secure loose rugs and runners throughout the home
Eliminate clutter from walkways and stairs
Ensure all stairways have sturdy handrails on both sides
Improve lighting in all areas, especially hallways and stairways
Keep frequently used items within easy reach to avoid overreaching
Repair loose floorboards or uneven flooring
Use non-slip mats under area rugs
Arrange furniture to create clear walking paths
Keep electrical and phone cords away from walking areas
Use chairs with arms for easier standing
Wear sturdy, non-slip footwear indoors

Bathroom Safety

The bathroom presents unique challenges due to wet surfaces and the need to transition between sitting and standing positions.

Install grab bars near the toilet and inside the shower or tub
Ensure grab bars are mounted directly into wall studs not drywall anchors
Use suction cup bars only for balance—they will not support your weight
Use a non-slip bath mat both inside and outside the tub or shower
Consider a shower chair or tub transfer bench for bathing
Install a raised toilet seat if needed
Ensure the bathroom has bright, even lighting
Keep a nightlight on for nighttime bathroom visits
Store toiletries within easy reach to avoid stretching
Set water heater to 120°F or below to prevent scalding
Consider replacing traditional tub with a walk-in shower

Kitchen Safety

The kitchen involves both fall risks and burn hazards that need attention.

Store heavy items at waist level to avoid bending or reaching
Use a sturdy step stool with handrails if reaching is necessary—never use chairs
Keep a fire extinguisher accessible and ensure it’s up to date
Wear short or close-fitting sleeves while cooking
Turn pot handles inward to prevent knocking them over
Clean up spills immediately to prevent slips
Ensure adequate lighting over work areas
Mark “on” and “off” positions clearly on appliance controls
Consider replacing gas stoves with electric if memory issues are present

Bedroom Safety

Since we spend significant time in the bedroom, it should be optimized for safe movement, especially at night.

Position the bed at an appropriate height for easy getting in and out
Keep a lamp or light switch within reach of the bed
Install nightlights along the path from bedroom to bathroom
Keep a phone or medical alert device within reach
Ensure smoke and carbon monoxide detectors are installed and functional
Avoid placing electrical cords near the bed where they could cause tripping
Use a firm mattress that provides adequate support
Keep a flashlight on the nightstand in case of power outages
Position cane or walker within easy reach if needed

Lighting Throughout the Home

Poor lighting significantly increases fall risk, yet it’s one of the easiest issues to address.

Increase wattage in existing fixtures (within safe limits)
Add lighting to dark hallways, stairways, and entrances
Install motion-sensor lights for convenience
Use nightlights in bathrooms, hallways, and bedrooms
Ensure light switches are accessible at room entrances
Replace burnt-out bulbs promptly
Consider adding illuminated light switches
Ensure outdoor entrances are well-lit

Stairway Safety

Stairs are high-risk areas that deserve special attention and modifications.

Ensure handrails extend the full length of stairs
Mark the edge of each step with bright, contrasting tape if not carpeted
Repair any loose steps or carpeting immediately
Ensure adequate lighting with switches at both top and bottom
Avoid storing items on stairs
Consider installing a stair lift if mobility is significantly impaired
Keep exterior stairs clear of ice and snow in winter

Fire and Emergency Safety

Quick response to emergencies can be lifesaving, so preparation is essential.

Install smoke detectors on every level and in each bedroom
Test smoke and carbon monoxide detectors monthly
Replace detector batteries at least annually
Keep fire extinguishers accessible in kitchen and garage
Create and practice an emergency exit plan
Post emergency numbers near all phones
Ensure house numbers are visible from the street for emergency responders
Consider a medical alert system, especially for those living alone
Keep a phone accessible at all times

Medication Safety

Medication management becomes more complex with age, and organization is key.

Use a pill organizer to track daily medications
Keep medications in original containers with clear labels
Store medications in a cool, dry place (not the bathroom)
Maintain an updated list of all medications and dosages
Discard expired medications properly
Ensure adequate lighting in areas where medications are taken
Set reminders for medication times
Consider a medication app for your smart phone
Keep a medication list in your wallet for emergencies

Technology and Communication

Staying connected improves both safety and quality of life.

Keep a charged cell phone accessible at all times
Consider a medical alert system with fall detection
Program emergency contacts into phones
Ensure phones have large buttons and clear displays if vision is impaired
Keep a list of emergency contacts posted in visible locations
Consider smart home devices that can control lights and temperature by voice

Outdoor Safety

The area outside the home also requires attention to prevent falls and injuries.

Repair cracked or uneven walkways and driveways
Ensure outdoor steps have sturdy handrails
Keep walkways clear of leaves, ice, and snow
Trim overgrown bushes and trees that obstruct paths
Ensure outdoor lighting is adequate for evening and early morning
Use non-slip materials on outdoor steps
Consider replacing steps with ramps if mobility is significantly limited
Place nonslip mats outside entry doors to reduce tracking in moisture or mud

This checklist is based on well-established safety guidelines from organizations like the CDC and National Fire Protection Association. The specific recommendations reflect current best practices in senior home safety. However, individual needs vary significantly based on specific mobility issues, health conditions, and home layouts, so some modifications may be more relevant than others for different situations.

Note: While these recommendations are widely applicable, it’s beneficial to have an occupational therapist or home safety specialist conduct a personalized assessment, as they can identify specific risks based on individual circumstances and home characteristics.

Grumpy opinions about everything.

Category: Medicine Page 4 of 9

Understanding Dementia: A Journey Through Memory Loss

America’s Healthcare Paradox: Why We Pay Double and Get Less

The Multitasking Myth

A1c Without Diabetes: Context Matters As Much As The Number

Understanding Parkinson’s Disease: From Diagnosis to Daily Living

The Correlation Mirage: How Good Intentions Go Wrong in Health Debates

Understanding Herd Immunity

Smartphones, Smartwatches & Wearables for Seniors

The Real Enemy of the Revolution: Disease

Home Safety Checklist for Senior Citizens